Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-30T16:51:22.788Z Has data issue: false hasContentIssue false
  • English
  • Français

Resolution of tardive dyskinesia after the switch to aripiprazole

Published online by Cambridge University Press:  24 June 2014

Chun-Hsin Chen ,
Winston W. Shen  and
Mong-Liang Lu
Chun-Hsin Chen
Affiliation:
Department of Psychiatry, Wan Fang Hospital and School of Medicine, Taipei Medical University, Taipei, Taiwan
Winston W. Shen
Affiliation:
Department of Psychiatry, Wan Fang Hospital and School of Medicine, Taipei Medical University, Taipei, Taiwan
Mong-Liang Lu*
Affiliation:
Department of Psychiatry, Wan Fang Hospital and School of Medicine, Taipei Medical University, Taipei, Taiwan
*
Dr Mong-Liang Lu Department of Psychiatry, Wan Fang Hospital, No. 111, Sec. 3, Hsin-Long Rd, Taipei 116, Taiwan. Tel: +886 2 29307930; Fax: +886 2 29302448; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Comment & Critique
Information
Acta Neuropsychiatrica , Volume 22 , Issue 3 , June 2010 , pp. 162 - 163
Copyright
Copyright © 2010 John Wiley & Sons A/S

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Jeste, DV, Caligiuri, MP.Tardive dyskinesia. Schizophr Bull 1993;19:303–315. CrossRefGoogle ScholarPubMed
Margolese, HC, Chouinard, G, Kolivakis, TT, Beauclair, L, Miller, R, Annable, L.Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: incidence and management strategies in patients with schizophrenia. Can J Psychiatry 2005;50:703–714. CrossRefGoogle ScholarPubMed
Tarsy, D, Baldessarini, RJ.Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? Mov Disord 2006;21:589–598. CrossRefGoogle ScholarPubMed
Correll, CU, Leucht, S, Kane, JM.Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry 2004;161:414–425. CrossRefGoogle ScholarPubMed
Malhi, GS, Pantelis, C.Is ‘this kinesia’ or tardive dystonia? Acta Neuropsychiatr 2008;20:216–217. CrossRefGoogle Scholar
Shapiro, DA, Renock, S, Arrington, Eet al. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 2003;28:1400–1411. CrossRefGoogle ScholarPubMed
Hirose, T, Uwahodo, Y, Yamada, Set al. Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile. J Psychopharmacol 2004;18:375–383. CrossRefGoogle Scholar
Inoue, A, Miki, S, Seto, Met al. Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum. Eur J Pharmacol 1997;321:105–111. CrossRefGoogle Scholar
Lim, HK, Pae, CU, Lee, C, Lee, CU.Tardive dystonic symptoms associated with aripiprazole treatment. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:589–590. CrossRefGoogle ScholarPubMed
Hettema, JM, Ross, DE.A case of aripiprazole-related tardive akathisia and its treatment with ropinirole. J Clin Psychiatry 2007;68:1814–1815. CrossRefGoogle ScholarPubMed
Rizos, E, Douzenis, A, Gournellis, R, Christodoulou, C, Lykouras, LP.Tardive dyskinesia in a patient treated with quetiapine. World J Biol Psychiatry 2007;8:1–4. Google Scholar
Lykouras, L, Rizos, E, Gournellis, R.Aripiprazole in the treatment of tardive dyskinesia induced by other atypical antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1535–1536. CrossRefGoogle ScholarPubMed
Kantrowitz, JT, Srihari, VH, Tek, C.Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot. J Clin Psychopharmacol 2007;27:525–526. CrossRefGoogle ScholarPubMed
Grant, MJ, Baldessarini, RJ.Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole. Ann Pharmacother 2005;39:1953. CrossRefGoogle ScholarPubMed
Sharma, A, Ramaswamy, S, Dewan, VK.Resolution of ziprasidone-related tardive dyskinesia with a switch to aripiprazole. Prim Care Companion J Clin Psychiatry 2005;7:36. CrossRefGoogle ScholarPubMed
Witschy, JK, Winter, AS.Improvement in tardive dyskinesia with aripiprazole use. Can J Psychiatry 2005;50:188. CrossRefGoogle ScholarPubMed
Karabulut, V, Gonenli, S, Yumrukcal, H, Bakım, B, Karamustafalıoglu, O.Aripiprazole improves neuroleptic-associated tardive dyskinesia, but it does not meliorate psychotic symptoms. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1342–1343. Google Scholar
Caykoylu, A, Ekinci, O, Yilmaz, E.Resolution of risperidone-induced tardive dyskinesia with a switch to aripiprazole monotherapy. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:571–572. CrossRefGoogle ScholarPubMed
Duggal, HS.Aripiprazole-induced improvement in tardive dyskinesia. Can J Psychiatry 2003;48:771–772. CrossRefGoogle ScholarPubMed
Miller del, D, Eudicone, JM, Pikalov, A, Kim, E.Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis. J Clin Psychiatry 2007;68:1901–1906. CrossRefGoogle Scholar